The global schizophrenia drugs market is growing at a modest CAGR of around 2.7% during the forecast period (2019-2025). Schizoaffective disorder is a chronic mental health disorder that involves symptoms of both schizophrenia and mood disorders such as bipolar disorder or MDD.